Starova Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
BC World Pharmaceutical Co., Ltd.
MFDS item code 201907232 · Approved 2019.10.15
This product's status changed to Approval withdrawn on 2024.11.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment for hypercholesterolemia and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct for patients with hypercholesterolemia and mixed dyslipidemia when diet or exercise is not sufficient. It is particularly beneficial for patients with primary hypercholesterolemia, familial hypercholesterolemia, and dysbetalipoproteinemia. It helps lower total cholesterol and LDL cholesterol levels to slow the progression of atherosclerosis. It is also used in pediatric patients aged 10 to 17 years with familial hypercholesterolemia. For men over 50 years and women over 60 years with high sensitivity C-reactive protein levels and cardiovascular risk factors, it helps reduce the risk of stroke, myocardial infarction, and vascular revascularization procedures. This medication is used to improve cardiovascular health and reduce the risk of cardiovascular diseases.
Administer 5 mg as an initial dose once daily at any time regardless of meals. The maintenance dose is 10 mg once daily, and should be adjusted appropriately based on LDL cholesterol levels, treatment goals, and patient response at intervals of 4 weeks or longer. The dose can be increased up to a maximum of 20 mg once daily.
Pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia are administered 5 mg to 20 mg once daily. The dosage is adjusted according to the individual patient's treatment goals, with adjustments made every 4 weeks.
This medication should not be used in certain patients. Firstly, individuals allergic to this medication should avoid it. Patients with severely impaired liver function or active liver disease should not use this medication. It should also not be administered to patients with muscle disorders or those experiencing muscle problems. Additionally, patients taking the immunosuppressant cyclosporine should not use this medication. Patients with very poor kidney function, pregnant or nursing women, and women of childbearing age who are uncertain about pregnancy should also avoid this medication. High doses (40 mg) are contraindicated, especially in patients at high risk for muscle problems. Patients with genetic metabolic disorders such as lactose intolerance should not take this medication. This medication should be used with caution in patients who consume alcohol excessively or have a history of liver disease, and liver function tests should be performed regularly before and during administration. Patients with conditions such as hypothyroidism or nephrotic syndrome should first have those conditions treated before using this medication. If symptoms such as muscle pain or weakness occur, the physician should be informed immediately, and if necessary, the medication should be discontinued. This medication can rarely cause severe adverse reactions such as serious skin reactions, liver damage, or muscle damage, so if such symptoms occur, treatment should be stopped immediately and medical consultation sought. Furthermore, this medication may interact with other drugs, so if taking any other medications, patients should inform their doctor or pharmacist. In particular, the risk of muscle damage may increase when used in conjunction with certain antivirals, immunosuppressants, antibiotics, or fibrate drugs. Pregnant or nursing women should not use this medication, and women who are capable of becoming pregnant should use appropriate contraception. In the event of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored. Dizziness may occur when driving or operating machinery, so caution is advised. It is important to have regular check-ups as advised by a physician during the course of this medication, and to consult a healthcare provider immediately if abnormal symptoms arise.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blistering, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory issues with cough + fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination changes
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture. It is recommended to keep the storage temperature between 1 to 30 degrees Celsius at room temperature to maintain the drug's efficacy and safety over time.
Pink round film-coated tablet
30 tablets (15 tablets/PTP (AluAlu) × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
BC World Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.